Dendritic Cells Archive - Seite 40 von 106 - IOZK

Anti-tumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.

2016-06-17/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-17 / J Clin Oncol 36, 2018 (suppl; abstr e24000)

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

2016-06-17/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-06-17 / Oncoimmunology 2016 Aug;5(8):e1201625

Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies

2016-06-09/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications /von 2016-06-09 / Expert Opin Biol Ther 2016 09;16(9):1113-23

Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.

2016-06-05/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr e12566)

Safety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).

2016-06-05/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1086)

Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.

2016-06-05/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1081)

5-year follow up for 72 metastatic melanoma patients treated with eltrapuldencel-T (CLBS20) vaccine.

2016-06-05/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 3090)

Association of increased survival in glioblastoma patients treated with dendritic cell vaccinations and temozolomide with increased activity of NK cells and ABCC3 expression.

2016-06-04/in Dendritic Cells, Glioblastoma, International Publications /von 2016-06-04 / J Clin Oncol 34, 2016 (suppl; abstr 2039)

A feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.

2016-06-03/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14579)

Dendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.

2016-06-03/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14586)